美国风湿病学会反应率无重叠：类风湿关节炎临床试验中报告反应的更好方法。 - Suppr

Suppr

超能文献

Non-overlapping American College of Rheumatology response rates: a better way to report response in rheumatoid arthritis clinical trials.

作者信息

Boers Maarten, Kostense Piet J

机构信息

VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Arthritis Rheum. 2010 Dec;62(12):3524-7. doi: 10.1002/art.27711.

DOI:10.1002/art.27711

PMID:20722016

Abstract

摘要

相似文献

Non-overlapping American College of Rheumatology response rates: a better way to report response in rheumatoid arthritis clinical trials.

Arthritis Rheum. 2010 Dec;62(12):3524-7. doi: 10.1002/art.27711.

Use of the American College of Rheumatology N (ACR-N) index of improvement in rheumatoid arthritis: argument in opposition.

Arthritis Rheum. 2005 Jun;52(6):1642-5. doi: 10.1002/art.21106.

World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.

J Rheumatol Suppl. 1994 Sep;41:86-9.

Use of the American College of Rheumatology N (ACR-N) index of improvement in rheumatoid arthritis: argument in favor.

Arthritis Rheum. 2005 Jun;52(6):1637-41. doi: 10.1002/art.21243.

Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities.

Ann Rheum Dis. 2006 Dec;65(12):1602-7. doi: 10.1136/ard.2005.048975. Epub 2006 Feb 27.

Criteria for improvement in rheumatoid arthritis: alternatives to the American College of Rheumatology 20.

J Rheumatol. 2004 May;31(5):856-66.

Measures of rheumatoid arthritis disease activity.

J Rheumatol. 2009 Feb;36(2):442-3; author reply 443-4. doi: 10.3899/jrheum.080923.

Patient-driven outcomes in rheumatoid arthritis.

J Rheumatol Suppl. 2009 Jun;82:33-8. doi: 10.3899/jrheum.090129.

Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.

Arthritis Rheum. 2005 Apr;52(4):1031-6. doi: 10.1002/art.20995.

Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?

Arthritis Rheum. 1998 Sep;41(9):1564-70. doi: 10.1002/1529-0131(199809)41:9<1564::AID-ART6>3.0.CO;2-M.

引用本文的文献

Favourable effect of a 'second hit' after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial.

Rheumatology (Oxford). 2023 Jun 1;62(6):2098-2105. doi: 10.1093/rheumatology/keac582.

Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids.

Rheumatology (Oxford). 2023 May 2;62(5):1824-1833. doi: 10.1093/rheumatology/keac547.

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease.

Ann Rheum Dis. 2016 Jul;75(7):1268-71. doi: 10.1136/annrheumdis-2016-209429. Epub 2016 Apr 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验